SCHEMBL17970032

SCHEMBL17970032

c1ccc(-c2cc(-c3cccc4c(-c5cc(-c6ccccc6)nc(-c6ccccc6)n5)cccc34)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.58
▸ KMT2A Q03164 10/20 0.58
▸ MAPT P10636 7/20 0.58
▸ ALDH1A1 P00352 6/20 0.58
▸ HPGD P15428 6/20 0.58
▸ NTSR1 P30989 1/20 0.58
▸ ADORA2A P29274 2/20 0.55
▸ ADORA1 P30542 2/20 0.55
▸ LMNA P02545 4/20 0.55
▸ KDM4E B2RXH2 3/20 0.55
▸ GLA P06280 1/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ CYP2C19 P33261 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ MAPK10 P53779 1/20 0.50
▸ MAPK1 P28482 1/20 0.49
▸ MAOB P27338 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17970010 0.96 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17969984 0.96 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17969993 0.96 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17996245 0.96 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17969986 0.96 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL17969935 0.94 MEN1 (0.58) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL14725231 0.94 MAPT (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL10051293 0.91 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16158773 0.91 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL12306181 0.91 MEN1 (0.54) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9954181-B2 Hetero-cyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2018-04-24 — — US disclosed
US-9954181-B2 Hetero-cyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2018-04-24 — — US disclosed
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) LG CHEM, LTD. (KR) 2016-08-11 — — US disclosed
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) LG CHEM, LTD. (KR) 2016-08-11 — — US disclosed
EP-3050879-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMTTING ELEMENT INCLUDING SAME LG Chem, Ltd. (KR) 2016-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160233430-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) CRY1, CRY2, PER2 MEN1 1048/4885KMT2A 986/4885MAPT 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback